Waters Corporation (WAT) stock analysis
WAT · Waters Corporation
Latest recorded price: USD 453.42
Model-estimated fair value: USD 167.93. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Healthcare · Diagnostics & Research
At $453.42, WAT trades 170.0% above the model's base-case value of $167.93. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $114.87 in the conservative case and $232.30 in the optimistic case, with a valuation confidence score of 90/100. Fiscal 2025 figures: revenue growth 2.1%, free cash flow margin 17.1%, ROIC 8.9%. The model flags 1 risk signal for this company.
Similar companies in Healthcare
- GeneDx Holdings Corp. (WGS)
- Agilent Technologies, Inc. Common Stock (A)
- Adaptive Biotechnologies Corporation (ADPT)
- CareDx, Inc. - Common Stock (CDNA)
- Charles River Laboratories International, Inc. (CRL)
- Castle Biosciences, Inc. (CSTL)
- Quest Diagnostics Incorporated Common Stock (DGX)
- Danaher Corporation Common Stock (DHR)